ELANElanco

Past and upcoming reports


Nov 6, 2026	Sep 30, 2026	Time not given	$0.20	Beat$0.27	Beat+35.0%	+8.70%

Nov 6, 2026 report

Elanco beat third-quarter EPS estimates, but pricing concerns leave the recovery thesis dependent on execution.

Elanco reported $0.27 EPS versus $0.20 estimated, a 35% beat, while shares rose 4.39% to $26.87 on November 9.

Beat

Elanco reported third-quarter EPS of $0.27 on November 6 versus the $0.20 estimate, a $0.07 or 35% beat.

No explicit post-earnings guidance update or quantified guidance signal was provided. guidance direction is unknown.

Shares rose $1.13, or 4.39%, to $26.87 on November 9, with 7.97 million shares traded. event-day and subsequent daily reactions were unavailable.

Third-quarter EPS reached $0.27 versus $0.20 expected, producing a 35% earnings beat.

The 4.39% gain to $26.87 signals positive initial reception despite pricing and execution risks.

Maintain a constructive-but-cautious bias. upgrade only if pricing pressure eases and forward EPS estimates stabilize.

Better case35%

The EPS beat supports continued recovery if management demonstrates that pricing pressure is not weakening sales and profit expectations.

Base case45%

The beat supports the shares, but mixed growth and quality signals keep the recovery dependent on incremental execution evidence.

Worse case20%

Pricing pressure could overwhelm the reported beat and undermine the recovery case through weaker sales, margins, or forecasts.

Hold unless forward EPS estimates are cut or pricing pressure produces operating margin below the reported 6.1% baseline.

Add only if forward EPS estimates stabilize or rise. avoid a new position if pricing concerns trigger analyst forecast cuts.

Scenario odds are a judgement, not measured.